SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as community members discuss its potential link to ExxonMobil's carbon capture technology for powering data centers, sparking optimism for the stock's future. The stock's recent surge in trading volume and price has investors comparing it to sector peer Bloom Energy, while analyzing options activity and potential news catalysts. Despite past performance concerns, some believe FuelCell is now well-positioned to capitalize on increasing demand for clean and reliable energy solutions.

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Metsera Inc.

Metsera Inc

MTSR is trending due to a potential bidding war between Novo Nordisk and Pfizer to acquire the company and its obesity drug pipeline, with Pfizer even filing a lawsuit related to the offers. Community members are discussing whether Pfizer will increase its bid or if another company like Eli Lilly could enter the competition. The surge in interest is also fueled by recent data, though some debate the drug's efficacy and side effect profile compared to competitors.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

Mimedx Group is trending due to CMS's final rule impacting skin substitute pricing, setting reimbursement at $127 per sq cm, a figure lower than some anticipated, sparking community debate about its effect on the company's competitive positioning and profitability. Some investors express concern over the implications of the ruling while others see it as a positive step towards eliminating fraudulent practices in the industry. Discussions also include speculation about potential M&A activity and long-term growth prospects amid the changing regulatory landscape.

BWX Technologies, Inc. engages in the supply and provision of nuclear components and products. It operates through the Government Operations and Commercial Operations segments. The Government Operations segment manufactures naval nuclear reactors, including the related nuclear fuel, for the U.S. Naval Nuclear Propulsion Program for use in submarines and aircraft carriers. The Commercial Operations segment fabricates commercial nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level waste and supplies nuclear-grade materials and precisely machined components for nuclear utility customers. The company was founded by Stephen Wilcox and George Babcock in 1867 and is headquartered in Lynchburg, VA.

BWX Technologies Inc

BWXT is trending as the community discusses its strong position in the nuclear sector and potential benefits from increased demand for nuclear energy, especially with the rise of AI and data centers. Some investors are drawing comparisons between BWXT and Nvidia, suggesting that BWXT could become a key player in the nuclear energy space similar to Nvidia's role in AI. High institutional ownership and government contracts are also being noted as potential drivers for growth.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilio is trending following strong Q3 earnings and a raised 2025 revenue outlook, driving positive sentiment among investors. The community is focused on price target increases from analysts and the potential impact of AI on Twilio's growth. Discussions also involve Twilio's market position and whether the company is undervalued, especially compared to its peers.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy ($PRO) is trending due to discussions around potential pumps and dumps, with community members actively debating price movements and trading strategies. The coin's association with Real World Assets (RWAs) and real estate transactions is also a prominent talking point. Some traders are expressing frustration with price volatility, while others remain bullish on its long-term potential.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors anticipate the upcoming Q3 financial results, with community chatter focusing on revenue and EPS expectations, and the potential for a double-digit swing in stock price based on the results. Discussions also include Briumvi's market position against competitors like Kesimpta and potential impacts from a Neuraxpharm sale, while some traders are eyeing potential buyout scenarios.

Tidal Trust II - YieldMax Dorsey Wright Featured 5 Income ETF

YieldMax Dorsey Wright Featured 5 Income ETF

Investors are closely watching $FEAT, a YieldMax ETF, as it transitions to weekly distributions, sparking discussions around payout estimates and the impact on cash flow. The community is also focused on the ETF's top holdings and its actively managed options strategies, particularly after YieldMax announced changes to their distribution schedule. Some are expressing concerns about the ETF's performance since inception, while others remain optimistic about its high yield potential.

Listed Funds Trust - Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF ($XXRP) is trending as traders discuss its potential for amplified gains relative to XRP, especially with upcoming catalysts like possible US government reopening and speculation around XRP ETF approvals in November. Community members are actively trading the ETF, sharing their buy-in points and strategies, while also debating its tracking accuracy and suitability for long-term holding versus short-term swings. Some users express concerns about decay and potential manipulation.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

Solid Power is trending as investors discuss its potential following a new collaboration with Samsung SDI and BMW to develop all-solid-state battery technology, though some question the nature of the agreement. Community members are debating the implications of Solid Power supplying electrolyte materials and the timeline for commercialization. Concerns about competition, partnerships, and technical challenges surrounding sulfide-based solid-state batteries are also circulating.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apogee Enterprises Announces CEO Transition

Apogee Enterprises, Inc. (Nasdaq: APOG) announced today that Apogee Enterprises Independent Chair Donald A. Nolan has been appointed as the Companys Chief Executive Officer, effective October 31...

Apogee Surpasses Earnings Estimates in Q2, Lowers FY26 Outlook

APOG beats Q2 earnings and revenue estimates on UW Solutions gains but trims its FY26 outlook amid margin pressure.

Apogee Enterprises Declares Quarterly Cash Dividend

Apogee Enterprises, Inc. (Nasdaq: APOG) announced today that its Board of Directors has declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on November 13, 2025, to...

Apogee Enterprises Reports Fiscal 2026 Second Quarter Results

Apogee Enterprises, Inc. (Nasdaq: APOG), a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications, today...

Apogee to Report Q2 Earnings: What's in the Cards for the Stock?

APOG's Q2 earnings may feel cost and supply pressures, but solid pricing and segment strength could lift results.


Apogee Bets on Momentum in Segments & Pricing Actions Amid High Costs

APOG rides strong segment gains, pricing actions and strategic moves, even as high costs and supply challenges weigh on results.

Lakeland Industries (LAKE) Q2 Earnings Top Estimates

Lakeland Industries (LAKE) delivered earnings and revenue surprises of +1,000.00% and -1.51%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Implied Volatility Surging for Apogee Stock Options

Investors need to pay close attention to APOG stock based on the movements in the options market lately.

Zacks Industry Outlook Highlights Array Digital Infrastructure, Liberty Latin America and Cambium Networks

Zacks highlights Array Digital Infrastructure, Liberty Latin America, and Cambium Networks as key players in the Wireless National industry, poised to gain from 5G, fiber densification, and IoT-driven demand.

Zacks Industry Outlook Highlights O-I Glass and Apogee Enterprises

O-I Glass and Apogee Enterprises emerge as top picks in Zacks' bullish Glass Products outlook, fueled by efficiency gains, innovation, and strong demand.

Apogee Enterprises, Inc. engages in the design and development of architectural products and services. It also provides architectural glass, aluminum framing systems and installation services for buildings, as well as value-added glazing products for custom picture framing. The company operates through the following segments: Architectural Framing Systems, Architectural Glass, Architectural Services, and Large-Scale Optical Technologies. The Architectural Framing Systems segment designs, engineers, fabricates and finishes aluminum window, curtainwall, storefront and entrance systems comprising the exterior of buildings. The Architectural Glass segment fabricates coated, glass used in custom window and wall systems. The Architectural Services segment integrates technical services, project management, and field installation services to design, engineer, fabricate, and install building glass and curtainwall systems. The Large-Scale Optical Technologies (LSO) segment manufactures value-added coated glass and acrylic products for custom framing, museum, and technical glass markets. The company was founded in 1949 and is headquartered in Minneapolis, MN.

Apogee Enterprises Inc.

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$1.04	--	--	N/A
Q2 '25	$0.85	$0.98	15.81%	BEAT
Q1 '25	$0.47	$0.56	19.79%	BEAT
Q4 '24	$0.88	$0.89	1.42%	BEAT
Q3 '24	$1.10	$1.19	8.18%	BEAT

APOG
Apogee Enterprises Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '25

Historical Earnings

Latest APOG News

APOGApogee Enterprises Inc.